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1. Abbreviations used in this paper: CTX, cerebrotendinous xanthomatosis; SSCP, single-strand conformational polymorphism.
brain-stem, spinal, and peripheral nerve disorder; and epileptic seizures (2) . In addition, osteoporosis with frequent bone fractures (3) and premature atherosclerosis (4) have recently been documented. Cholestanol, the 5a-dihydro derivative ofcholesterol, is found in all tissues, particularly in the Achilles tendons, brain, and lungs (5, 6) . The clinical diagnostic criteria include the demonstration of increased concentrations of bile alcohols in the serum and urine with low to normal plasma cholesterol concentrations (7) . If untreated, CTX is a slowly progressive lethal disease (5) . Early diagnosis of CTX is crucial inasmuch as long-term treatment with chenodeoxycholic acid (8) with or without an hydroxymethylglutaryl coenzyme A reductase inhibitor (9) may prevent the neurological complications of the disease.
Based on intermediary metabolism studies, Salen and coworkers (10) postulated in 1979 that a defect in a microsomal sterol 24S-hydroxylase causes CTX. In 1980, Oftebro et al. (11) reported that a defect in the mitochondrial sterol 26-hydroxylase (currently designated 27-hydroxylase) is the cause of CTX. These authors could detect no sterol 26-hydroxylase activity in a liver biopsy from a Norwegian CTX subject. Several subsequent studies employing fibroblasts from different CTX patients have confirmed a lack of mitochondrial 26-hydroxylase activity in this disease (12) .
The sterol 27-hydroxylase (EC 1.14.13.15) is a mitochondrial enzyme catalyzing the initial steps in the oxidation of the side chain of sterol intermediates in the pathway for metabolism and excretion of cholesterol in mammals. The enzymatic hydroxylation of 5f3-cholestane-3a,7a, 12a-triol at C-27 occurs in mitochondria and is catalyzed by an enzyme complex comprising sterol 27-hydroxylase, ferredoxin, and NADPH-ferredoxin reductase (13) . The sterol 27-hydroxylase was purified and characterized as mitochondrial member ofthe cytochrome P450 family ( 1 4, 15) . This enzyme hydroxylates a spectrum of sterol substrates as well as vitamin D3 (14, 16) . In agreement with this finding, abnormal vitamin D metabolism has been recently observed in CTX patients (3) . Molecular cloning of the human sterol 27-hydroxylase cDNA has shown that the protein consists ofa 498-amino acid mature enzyme and a 33-amino acid mitochondrial signal sequence (17) . RNA blotting experiments demonstrated mRNAs of -1.8-2.2 kb in liver and fibroblast cells. The gene encoding human sterol 27-hydroxylase (CYP27) has been mapped to the distal portion (q33-qter) of the long arm of chromosome 2 (18) . After the molecular cloning ofthe human sterol 27-hydroxylase complementary DNA, two missense mutations were characterized in CTX cases (18) . Identification of mutations that result in absence of any detectable mRNA required the characterization of the sterol 27-hydroxylase gene structure, a major goal of the current investigation.
Although rare in most populations, an interesting and experimentally approachable instance of abnormally high frequency of CTX has been reported in Israel ( 19) . This finding mandates introduction ofdirect detection methods to diagnose the heterozygote state. The molecular characterization of mutations causing CTX in Moroccan Jews was an additional objective of the present study.
Methods
Determination ofthe sterol 27-hydroxylase gene structure Genomic cloning. A human lymphocyte genomic library (in Lambda Dash) was obtained from Stratagene, Inc. (La Jolla, CA) and screened with 32P-labeled oligonucleotides complementary to cDNA sequences of the human sterol 27-hydroxylase cDNA. One clone (HG27-4) hybridized with oligonucleotide JC2 1 5'-TCCGGCGGCGGCAACGGA-GCTTAGA-3' derived from 5' sequences of the cDNA. Three clones (HG27-1,2,3) hybridized with oligonucleotides JC25 5'-AAGCAG-CGCTCTATACGGATGCTTT-3' and JC33 5'-TGGTCCCCACAA-ACTCCCGGATCATA-3' derived from other coding sequences including the 3' region ofthe cDNA. An EcoRI fragment ofclone HG27-1 was subcloned into a pBS vector (Stratagene, Inc.) and designated p27OHGE. The BamHI-SphI fragment of p27OHGE was subcloned into bacteriophage M13 mpl8, mpl9 vectors (New England Biolabs, Beverly, MA) and designated 27OHBS. A Sacd fragment from HG27-4 was subcloned into a pBS vector and designated p27OHGS. The SacdSmaI fragment of this plasmid and a PstI fragment of HG27-4 were subcloned into bacteriophage Ml 3 and were designated 270HSS and 270HPS, respectively (Fig. 1 A) . PCR amplifcation. We used PCR amplification (20) Medical Center, Beer-Sheba). The diagnosis was verified according to the previously defined clinical and laboratory criteria (1) . The phenotypic characteristics and the pedigree structure ofthree patients that are included in the current study had been previously reported by Berginer and Abeliovich (19 Biochemical analyses. Plasma total triglyceride, cholesterol, and HDL-cholesterol levels were determined on fasting blood samples using commercially available diagnostic kits (Boehringer Mannheim Gmb H, Mannheim, FRG). Plasma LDL-cholesterol levels were calculated according to the Friedewald-Levy formula (24). Plasma cholestanol levels were determined by the gas chromatographic method (6, 25) .
RNA and DNA mutation analysis. Skin biopsies were obtained from the CTX patients, fibroblast cultures were established, and total cellular RNA was extracted in 4 M guanidine thiocyanate (26) . The RNA was denatured in 3 M glyoxal, subjected to electrophoresis on 1.6% agarose gel (27) and transferred to a nylon-based membrane (Biotrans) and hybridized with an [a-32P]dCTP-labeled full-length human sterol 27-hydroxylase cDNA probe (22) .
Southern blotting analysis was performed as described above using genomic DNA that had been extracted from blood leukocytes obtained from the CTX patients and probed with an identical probe. To identify the mutations that cause CTX in Jewish patients of Moroccan extraction, we have used PCR amplification (20) of genomic DNA and single-strand conformational polymorphism (SSCP) analysis (28) . All exons and the 5' flanking region ofthe sterol 27-hydroxylase gene were amplified using the oligonucleotides listed in Table I . The PCR reactions included 10 uCi of [a-32P]dCTP and the conditions were as described above. The PCR products ofthe 5' region ofthe gene and exons 6-9 were digested with HaeII and AvaIl restriction endonucleases, respectively, before analysis on a 6% nondenaturing polyacrylamide gel containing 10% (vol/vol) glycerol. After the identification of abnormally migrating bands, the appropriate exon was PCR-amplified using similar oligonucleotides that include six-nucleotide 5' extensions with the consensus sequence for BamHI (upstream oligonucleotides) and SphI (downstream oligonucleotides) restriction endonucleases, respectively, and three additional irrelevant nucleotides (ATA). The PCR products were analyzed on a 1.5% agarose gel, the appropriate band was extracted, purified and subjected to BamHI/SphI digestion followed by subcloning into bacteriophage Ml 3. Sequence analysis of both strands of two independent M 13 clones obtained from two separate PCR reactions was performed using the dideoxynucleotide chain termination method (29) .
Direct detection of the mutant alleles. Direct detection methods were used to confirm the presence of the two mutations in genomic DNA samples from the four index cases. The mutation in exon 4 creates a new BpmI restriction site and deletes a FokI site. Intron 4 mutation does not change a restriction site and therefore we used the PCR-primer-introduced restriction analysis method (30) to create a new Styl site only in the mutant, PCR-amplified allele. The upstream oligonucleotide primer 27OHMM (5'-CTTTCCTCTTCTCTGTT-GCTTTCCC-3') included a single base substitution (underlined) where adenosine was substituted by cytosine, three nucleotides upstream to the beginning of exon 5. The downstream oligonucleotide primer was identical to the 3' oligonucleotide primer used for amplification ofexon 5 (Table I ). We applied the SSCP method (as described above) to detect the mutant gene and determine its frequency in 250 unrelated individuals of Jewish Moroccan extraction.
Results
Structure ofthe sterol 27-hydroxylase gene. After screening of the human genomic library, four hybridization-positive clones were isolated. The genomic inserts were probed by using 32P-labeled oligonucleotides derived from the human sterol 27-hydroxylase cDNA. Three clones hybridized to oligonucleotides derived from the 3' coding region and the fourth with an upstream oligonucleotide.
The structure of the gene was derived from plasmid mapping and confirmed by Southern blotting analysis of control human genomic DNA (Fig. 1) . The gene spans at least 18.6 kb and includes nine exons and eight introns. The exact locations of the introns were determined by DNA sequencing, and their sizes were verified by the PCR. As no overlapping genomic bacteriophage X clones were found, the minimal size of intron 1 was estimated from Southern blotting ofgenomic DNA using Sacd restriction analysis and hybridization with an exon 1-specific probe (data not shown). The DNA sequences at the intron-exon junctions are shown in Table II and obey the GT/ AG rule of eukaryotic genes (31 ) . As indicated in Fig. 1 , the sizes ofthe DNA fragments generated with five restriction endonucleases agreed with those predicted from the gene map, confirming that the sterol 27-hydroxylase is a single copy gene. The CCTTGGgtcagaatat 1820
Capital letters and numbers refer to exon sequences, with the A of the ATG initiation codon being assigned number 1; small letters refer to intron sequences; amino acids are numbered according to Cali and Russell (17) .
sequence encoding the "extrapeptide" mitochondrial signal is located in exon 1, the putative ferredoxin binding site in the 3' end ofexon 6, and the predicted heme binding cysteine residue in exon 8. These sites were determined based on the structure of the cDNA and protein (18) .
DNA sequencing of the 5' flanking region. The DNA sequence of the 5' untranslated region is shown in Fig. 2 . This sequence was derived from two partially overlapping bacteriophage Ml 3 clones (270HSS and 270HPS). The sequence includes 500 bp, displays a high G+C content and possible binding sites for the transcription factor Sp I and the liver transcription factor, LF-B1. A canonical TATA sequence and CAAT box did not appear to be present in the immediate 5'-flanking region.
Clinical manifestations and biochemical analyses. (Table III) Sequence analysis revealed that the mutation in exon 4 is a deletion of thymidine that results in a frameshift and in premature termination codon 35 nucleotides downstream, the second mutation, a null mutation, is a guanosine to adenosine substitution at the 3' splice acceptor site of intron 4 (Fig. 5 CTX cases (0.0000433 X 498,000 X 0.914) that result from the two mutant alleles in nonconsanguineous marriages may exist. So far, only two nonconsanguineous Jewish Moroccan CTX families are known: family 204 and another family which is not included in this study (Berginer, unpublished estimate for homozygosity is therefore 0.0000433. Inasmuch as the current Jewish population that originated from Morocco in Israel is 498,000 (32) and the degree of interethnic mixture (calculated from our sample) is only 8.6%, it suggests that 20
EXON 4 Discussion
Here we show that in Moroccan Jews, CTX is caused by two distinct sterol 27-hydroxylase gene mutations. These two mutations, a deletion of thymidine in exon 4 and a guanosine to adenosine substitution at the 3' splice acceptor site of intron 4, in addition to an estimate ofcarrier frequency, provide an indication of the expected prevalence of CTX in the Israeli Jewish Moroccan community. Moroccan Jews have been socially isolated from non-Jews in Morocco and it has been established that they resemble other Jewish populations with regard to several polymorphic genetic systems (33) . The possibility of the existence of a founder mutation in the Jewish Moroccan population is related to the unique demographic characteristics of this ethnic group. Some ofits ancestors immigrated to Morocco before the destruction of the Second Temple (34) where they intermarried with the Berber tribes (35, 36) . After the Arab conquest of Morocco in the 8th century the Jews lived in ghettos where inbreeding was common (37) . This population was diluted with a massive Jewish refugee immigration from the Iberian peninsula at the end of the 15th century. This Moroccan Jewish community then migrated almost exclusively to Israel.
The fact that two mutations are prevalent in this community is also compatible with a founder mechanism as has recently been shown for familial hypercholesterolemia in Afrikaners (38) and in the Finnish population (39) . (Table I) . Exon 5 was amplified using oligonucleotides 5a and 5b (Table I) . After amplification, the PCR products were heat denaturated and subjected to electrophoresis on a 6% nondenaturing polyacrylamide gel containing 10% glycerol followed by autoradiography for 24 h. ning. These observations suggest that the mechanism for the development of dementia in CTX is complex and may be related at least in part to the toxic effect of bile alcohols.
The absence oftendon xanthomas in patient 201-8 is striking especially when compared to her sister (201-7) and may be related to her very low LDL-cholesterol levels. Low LDL-cholesterol levels are commonly found in CTX and could possibly be related to overexpression of LDL receptors (46) . In some cases LDL-cholesterol levels are elevated as in patient 201-7 where the markedly increased plasma LDL-cholesterol concentration could contribute to the development of severe tendon xanthomas in this relatively young patient.
The current investigation reveals the structure of the human sterol 27- (48) (49) (50) . 2494 Leitersdorf et al. The gene for the sterol 27-hydroxylase (CYP27) belongs to a group of now over 150 cytochrome P450 genes (51) . The sterol 27-hydroxylase gene that includes nine exons, is similar in structure to CYPIJBI and CYPJJB2 genes encoding the human steroid 1 l$-hydroxylase (52) . To date, cytochrome P450 genes have been classified into 27 families, each defined as unique when having < 40% resemblance to members of other families. All genes within a given family are predicted to have the same number of exons and similar exon/intron boundaries (53) , suggesting that the rabbit 27-hydroxylase (54) and the rat 27-hydroxylase (55, 56) genes will be similar in structure to the human gene.
The enzyme sterol 27-hydroxylase belongs to the mitochondrial P450s which require ferredoxin as a co-factor and ferredoxin reductase for electron transfer. Several conserved domains have been recognized in the P450 mitochondrial proteins, suggesting that the organization ofthe exons might correlate with functional domains of the protein. We found that the sequence encoding the hydrophobic "extrapeptide" mitochondrial signal is located in exon 1 and that the predicted hemebinding cysteine residue resides in exon 8 of the gene. The putative ferredoxin binding site (57) is located at the 3' end of exon 6. Three potential binding sites for the transcription factor SPl and one for the liver transcription factor LF-B1 were also identified. This is significant as the expression ofthe sterol 27-hydroxylase gene in the liver appears to be independent of regulation by cholesterol (17, 54) . SPl has been widely described as playing a role in the expression of "house-keeping" genes (58), while the liver transcription factor LF-B1 is required for the expression of liver specific genes. The importance ofthese sites for the transcriptional control ofthe human sterol 27-hydroxylase remains to be elucidated.
Elucidation ofthe sterol 27-hydroxylase gene structure and analysis of mutant alleles that underlie CTX may provide the basis for future research in several important directions. These directions include the analysis ofthe regulatory mechanisms of sterol 27-hydroxylase gene expression, the molecular diagnosis ofCTX at the pre-symptomatic stage, and the study ofpathogenetic mechanisms that lead to the major manifestations of the disease in molecularly defined CTX cases. These studies are currently underway in our laboratory.
